#fda-advisory-panel

[ follow ]
www.nytimes.com
4 months ago
Medicine

F.D.A. Panel Rejects MDMA-Aided Therapy for PTSD

The FDA advisory panel rejected MDMA-assisted therapy for PTSD due to concerns about study designs, participants' ability to guess MDMA use, and potential biases. [ more ]
Inverse
3 months ago
Medicine

MDMA's Future As A Treatment For PTSD Is In Question

The FDA expert panel rejected MDMA as a treatment for PTSD due to effectiveness and risk concerns, despite existing use in Australia. [ more ]
[ Load more ]